Your search returned 22 results.

Sort
Results
1.
124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G
Local accession number:
  • 2013_166
2.
Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Endocrinology
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L
Local accession number:
  • 2013_165
3.
The utility of "Blind" 131 I treatment for differentiated thyroid cancer: an educational exhibit. MedStar authors:
  • Elboga, Umut
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D
Local accession number:
  • 2013_160
4.
Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_162
5.
Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
Local accession number:
  • 2013_16
6.
Number of Foci of Functioning Thyroid Tissue Remaining after Thyroidectomy for Differentiated Thyroid Cancer: Institutional Experience. MedStar authors:
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Mete, Mihriye
  • Van Nostrand, Douglas
PMID:
  • 28553178
Year: 2017
Citation:
  • World Journal of Nuclear Medicine. 16(2):122-125, 2017 Apr-Jun
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Khorjekar G, Kulkarni K, Mete M, Van Nostrand D
7.
Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_161
8.
30 mCi exploratory scan for two-step dosimetric 131I therapy in differentiated thyroid cancer patients: A novel approach and case report. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Cristiane J
  • Kulkarni, Kanchan
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 33354183
Year: 2020
Citation:
  • World Journal of Nuclear Medicine. 19(3):266-270, 2020 Jul-Sep.
Institution:
  • MedStar Health Research Institute Jeyce
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Case Reports
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Gomes-Lima CJ, Kulkarni K, Van Nostrand D, Wartofsky L, Wu D
9.
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31616967
Year: 2019
Citation:
  • European Journal of Nuclear Medicine & Molecular Imaging. 2019 Oct 15
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Flux G, Giovanella L, Luster M, Muylle K, van Nostrand D, Verburg FA
10.
Brief progress report from the intersocietal working group on differentiated thyroid cancer. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 32166513
Year: 2020
Citation:
  • European Journal of Nuclear Medicine & Molecular Imaging. 2020 Mar 12
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Bardies M, Bernet V, Bourguet P, Daniels GH, Draganescu C, Fuhrer-Sakel D, Greenspan B, Gulec S, Hegedus L, Jonklaas J, Luster M, Oyen W, Smit J, Tuttle RM, Van Nostrand D, Verburg FA, Zerdoud S
11.
David C. Moses, MD (1940-2020). MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 32499287
Year: 2020
Citation:
  • Journal of Nuclear Medicine. 61(6):20N, 2020 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
12.
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors:
  • Atkins, Francis
  • Garcia, Carlos
  • Van Nostrand, Douglas
PMID:
  • 28104741
Year: 2017
Citation:
  • Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D
13.
Radioiodine Theranostics: Increasing Dialogue and Collaboration. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 28970353
Year: 2017
Citation:
  • Journal of Nuclear Medicine. 58(10):19N-20N, 2017 Oct
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
14.
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.[Erratum appears in J Nucl Med. 2012 May;53(5):830] MedStar authors:
  • Atkins, Frank B
  • Burman, Kenneth D
  • Chennupati, Shyam P
  • Kharazi, Pejman
  • Khorjekar, Gauri R
  • Mete, Mihriye
  • Moreau, Shari
  • O'Neil, Jeff
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 22315442
Year: 2012
Citation:
  • Journal of Nuclear Medicine. 53(3):359-62, 2012 Mar.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins FB, Burman KD, Chennupati SP, Kharazi P, Khorjekar GR, Mete M, Moreau S, O'Neil J, Van Nostrand D, Wartofsky L
15.
The BEIR VII Estimates of Low-Dose Radiation Health Risks Are Based on Faulty Assumptions and Data Analyses: A Call for Reassessment. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 29475999
Year: 2018
Citation:
  • Journal of Nuclear Medicine. 59(7):1017-1019, 2018 07.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Greenspan BS, Maurer AH, Phillips WT, Sacks B, Siegel JA, Silberstein EB, Taylor AT, Van Nostrand D
16.
Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors:
  • Bethancourt, Evelyn
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Orquiza, Michael
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 30361377
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(5):638-643, 2019 05.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D
17.
Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31160436
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(6):20N-22N, 2019 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
18.
Overview of the Martinique Meetings: What Has Been Established and Where Are We Going?. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31160431
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(6):15N, 2019 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Greenspan BS, Gulec S, Van Nostrand D
19.
The Martinique Principles. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31227575
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(9):1334-1335, 2019 09.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Letter
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Dillehay G, Greenspan BS, Gulec S, Van Nostrand D
20.
SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 35649660
Year: 2022
Citation:
  • Journal of Nuclear Medicine. 63(6):15N-35N, 2022 Jun.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Avram AM, Giovanella L, Greenspan B, Lawson SA, Luster M, Ovcaricek PP, Peacock JG, Silberstein E, Tulchinsky M, Van Nostrand D, Verburg FA, Vrachimis A
21.
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Cristiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 31451488
Year: 2020
Citation:
  • Journal of Nuclear Medicine. 61(3):397-404, 2020 03.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bloom G, Burman KD, Gomes-Lima CJ, Van Nostrand D, Wartofsky L, Wu D
22.
Advanced differentiated thyroid cancer: when to stop radioiodine?. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31271271
Year: 2019
Citation:
  • The Quarterly Journal of Nuclear Medicine. 63(3):267-270, 2019 Sep.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Giovanella L, van Nostrand D
Pages

Powered by Koha